Clinical Trial Update: NO Re-excision MelanomA - NORMA 2 [Phase 3]

View source ↗

Summary

NORMA 2 is a Phase 3 clinical trial in melanoma evaluating a no-reexcision strategy; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Marieke Goodijk | Conditions: Melanoma (Skin Cancer) | Phase 3 | Status: RECRUITING